» Articles » PMID: 15545822

Histocompatibility Leukocyte Antigen-D Related Expression is Specifically Altered and Predicts Mortality in Septic Shock but Not in Other Causes of Shock

Overview
Journal Shock
Date 2004 Nov 17
PMID 15545822
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Although the expression of monocyte histocompatibility leukocyte antigen (HLA)-DR has been shown to be decreased during human sepsis, its level of expression in other nonseptic critical conditions is unclear. The aim of this study was to compare the level of HLA-DR expression on circulating monocytes among patients with septic, hemorrhagic, and cardiogenic shocks and severe sepsis without shock. At admission, HLA-DR expression was exclusively decreased in patients with septic shock (n = 30; P < 0.001), whereas the expression was similar between the other studied groups: cardiogenic shock (n = 16), hemorrhagic shock (n = 11), severe sepsis without shock (n = 18), and healthy volunteers (n = 8). HLA-DR expression was not predictive for overall mortality, but at day 1, an HLA-DR expression of less than 14 of mean fluorescence intensity (that corresponds to 40% labeled monocytes) was predictive of mortality exclusively in patients with septic shock (odds ratio, 11.4 and 95% confidence interval, 1.7; 78.4; P < 0.008). Catecholamine infusion, mechanical ventilation, positive blood culture, and number of units of blood or plasma transfused did not correlate with decreased HLA-DR expression. Thus, the decrease in HLA-DR expression is specific to septic shock and is associated, in septic shock patients, with increased mortality risk.

Citing Articles

Purified Granulocyte Concentrates from Buffy Coats with Extended Storage Time.

Klinkmann G, Doss F, Doss S, Schwarz A, Reichert S, Reuter D Transfus Med Hemother. 2024; 51(6):383-392.

PMID: 39664462 PMC: 11630903. DOI: 10.1159/000537698.


Changes in monocyte subsets in volunteers who received an oral wild-type Typhi challenge and reached typhoid diagnosis criteria.

Toapanta F, Hu J, Shirey K, Bernal P, Levine M, Darton T Front Immunol. 2024; 15:1454857.

PMID: 39263222 PMC: 11388309. DOI: 10.3389/fimmu.2024.1454857.


Extracorporeal immune cell therapy of sepsis: ex vivo results.

Klinkmann G, Wild T, Heskamp B, Doss F, Doss S, Arseniev L Intensive Care Med Exp. 2022; 10(1):26.

PMID: 35708856 PMC: 9202321. DOI: 10.1186/s40635-022-00453-8.


Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?.

Winkler M, Rissiek A, Priefler M, Schwedhelm E, Robbe L, Bauer A PLoS One. 2017; 12(8):e0182427.

PMID: 28771573 PMC: 5542660. DOI: 10.1371/journal.pone.0182427.


Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study.

Drewry A, Ablordeppey E, Murray E, Beiter E, Walton A, Hall M Crit Care. 2016; 20(1):334.

PMID: 27760554 PMC: 5072304. DOI: 10.1186/s13054-016-1505-0.